Over 30 years of deep life sciences industry experience with a wide range of expertise in corporate governance, capital markets, licensing and strategic collaborations
To create leading company developing medicines targeting metalloenzymes
Passengers arriving from 6 high-risk countries are now mandatorily required to upload their negative RT-PCR test
Cipla and Ethris partner for the development of mRNA-based therapies
The current approval is first of the many fillings made by the company's CDMO partners from the flagship facility in Bangalore
The vectored intranasal delivery platform gives us the capability for rapid product development, scale-up, easy and painless immunization during public health emergencies and pandemics
This partnership stemmed from a successful customer-supplier relationship spanning several years.
He has global experience in strategic and operational leadership including at Board, CEO and Senior Corporate levels
The Institute will focus on increasing preparedness and laboratory capabilities for identification of novel and unknown zoonotic agents
Subscribe To Our Newsletter & Stay Updated
